Lipella Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch LIPO and buy or sell other stocks, ETFs, and their options commission-free!About LIPO
Lipella Pharmaceuticals, Inc. develops and commercializes lipid-based therapies for common bladder syndromes. It offers LP-08 which consists of Sphingomyelin Phospholipid bilayers separated by aqueous compartments, LP-09, a liposomal formulation of Botulinum toxin, and LP-10, a proprietary liposomal formulation of Tacrolimus, a potent immunosuppressant and anti-inflammatory agent.
CEOJonathan Kaufman
CEOJonathan Kaufman
Employees7
Employees7
HeadquartersPittsburgh, Pennsylvania
HeadquartersPittsburgh, Pennsylvania
Founded2005
Founded2005
Employees7
Employees7
LIPO Key Statistics
Market cap1.92K
Market cap1.92K
Price-Earnings ratio-3.97
Price-Earnings ratio-3.97
Dividend yield—
Dividend yield—
Average volume434.56K
Average volume434.56K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.50
52 Week high$1.50
52 Week low$0.2804
52 Week low$0.2804
Stock Snapshot
As of today, Lipella Pharmaceuticals(LIPO) shares are valued at $0.00. The company's market cap stands at 1.92K, with a P/E ratio of -3.97.
Lipella Pharmaceuticals(LIPO) stock opened on 2026-08-09 at —. The price climbed to — and dipped to —.
Lipella Pharmaceuticals(LIPO) shares are trading with a volume of 0, against a daily average of 434.56K.
In the last year, Lipella Pharmaceuticals(LIPO) shares hit a 52-week high of $1.50 and a 52-week low of $0.28.
In the last year, Lipella Pharmaceuticals(LIPO) shares hit a 52-week high of $1.50 and a 52-week low of $0.28.
People also own
Based on the portfolios of people who own LIPO. This list is generated using Robinhood data, and it’s not a recommendation.